Corcept Therapeutics Incorporated (0I3Q.L) LSE
32.12
-0.24(-0.74%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
32.12
-0.24(-0.74%)
Currency In USD
| Market Cap | 3.61B |
| Enterprise Value | 3.5B |
| P/E Ratio | 33.7 |
| PEG Ratio | -6.74 |
| Price/Sales Ratio | 4.49 |
| Price/Book Ratio | 5.15 |
| Enterprise/Revenue | 4.34 |
| Enterprise/EBITDA | 57.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.13 |
| Operating Margin | 0.06 |
| Return On Assets | 0.12 |
| Return On Equity | 0.15 |
| Revenue | 761.41M |
| Revenue/Share | 7.33 |
| Gross Profit | 748.43M |
| EBITDA | 68.35M |
| Net Income | 99.65M |
| Diluted EPS | 0.82 |
| Total Cash | 372.15M |
| Total Cash/Share | 3.58 |
| Total Debt | 6.11M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.92 |
| Book Value Per Share | 6.24 |
| 52-Week Change | -40.72 |
| 52-Week High | 34.13 |
| 52-Week Low | 20.76 |
| Moving Average 50 Days | 23.44 |
| Moving Average 200 Days | 26 |
| Average Volume | 2,318 |
| Shares Outstanding | 99.72M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |